Vera Therapeutics VERA Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's interest expense?
- Vera Therapeutics (VERA) reported interest expense of $1.82M in Q1 2026.
- How has Vera Therapeutics's interest expense changed year-over-year?
- Vera Therapeutics's interest expense increased by 1.7% year-over-year, from $1.79M to $1.82M.
- What is the long-term trend for Vera Therapeutics's interest expense?
- Over 4 years (2021 to 2025), Vera Therapeutics's interest expense has grown at a 340.5% compound annual growth rate (CAGR), from $20K to $7.53M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.